Adam Boxer (University of California, San Francisco) discusses his research, published in August issue of The Lancet Neurology, on diagnostic performance of tau biomarkers in neurodegenerative diseases.

Read the full article:
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(21)00214-3/fulltext